نتائج البحث - Thomas Hultsch

  • يعرض 1 - 17 نتائج من 17
تنقيح النتائج
  1. 1
    Immunomodulation and Safety of Topical Calcineurin Inhibitors for the Treatment of Atopic Dermatitis

    Immunomodulation and Safety of Topical Calcineurin Inhibitors for the Treatment of Atopic Dermatitis حسب Thomas Hultsch, Alexander Kapp, Jonathan M. Spergel

    منشور في 2005
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Omalizumab therapy in atopic dermatitis: depletion of IgE does not improve the clinical course – a randomized, placebo‐controlled and double blind pilot study

    Omalizumab therapy in atopic dermatitis: depletion of IgE does not improve the clinical course – a randomized, placebo‐controlled and double blind pilot study حسب Peter Maximilian Heil, Dieter Maurer, Brigitte Klein, Thomas Hultsch, Georg Stingl

    منشور في 2010
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Pimecrolimus Enhances TLR2/6-Induced Expression of Antimicrobial Peptides in Keratinocytes

    Pimecrolimus Enhances TLR2/6-Induced Expression of Antimicrobial Peptides in Keratinocytes حسب Amanda S. Büchau, Jürgen Schauber, Thomas Hultsch, Anton Stuetz, Richard L. Gallo

    منشور في 2008
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Immunophilin ligands demonstrate common features of signal transduction leading to exocytosis or transcription.

    Immunophilin ligands demonstrate common features of signal transduction leading to exocytosis or transcription. حسب Thomas Hultsch, M W Albers, Stuart L. Schreiber, R J Hohman

    منشور في 1991
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Decreased release of histamine and sulfidoleukotrienes by human peripheral blood leukocytes after wasp venom immunotherapy is partially due to induction of IL-10 and IFN-γ production of T cells

    Decreased release of histamine and sulfidoleukotrienes by human peripheral blood leukocytes after wasp venom immunotherapy is partially due to induction of IL-10 and IFN-γ producti... حسب Melanie Pierkes, Iris Bellinghausen, Thomas Hultsch, Gudrun Metz, Jürgen Knop, Joachim Saloga

    منشور في 1999
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    The effect of anti-IgE treatment on in vitro leukotriene release in children with seasonal allergic rhinitis

    The effect of anti-IgE treatment on in vitro leukotriene release in children with seasonal allergic rhinitis حسب Matthias Kopp, Jens Brauburger, Frank Riedinger, Daniel Glez‐Peña, Gabriele Ihorst, Wolfgang Kamin, Stefan Zielen, C. Bez, Frank Friedrichs, Andrea von Berg, Kerstin Gerhold, Eckard Hamelmann, Thomas Hultsch, Joachim Kuehr

    منشور في 2002
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Improvement of atopic dermatitis with dupilumab occurs equally well across different anatomical regions: data from phase <scp>III</scp> clinical trials

    Improvement of atopic dermatitis with dupilumab occurs equally well across different anatomical regions: data from phase <scp>III</scp> clinical trials حسب Andrew Blauvelt, David Rosmarin, Thomas Bieber, Eric L. Simpson, Jerry Bagel, Margitta Worm, Mette Deleuran, Norito Katoh, Makoto Kawashima, Brad Shumel, Z. Chen, Ana B. Rossi, Thomas Hultsch, Marius Ardeleanu

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Carta
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical t

    Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is m... حسب Marjolein de Bruin‐Weller, Diamant Thaçi, Catherine Smith, Kristian Reich, Michael J. Cork, Allen Radin, Q. Zhang, Bolanle Akinlade, A. Gadkari, Laurent Eckert, Thomas Hultsch, Z. Chen, Gianluca Pirozzi, Neil M.H. Graham, Brad Shumel

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Dupilumab provides important clinical benefits to patients with atopic dermatitis who do not achieve clear or almost clear skin according to the Investigator's Global Assessment: a pooled analysis of data from two phase <scp>III</scp> trials

    Dupilumab provides important clinical benefits to patients with atopic dermatitis who do not achieve clear or almost clear skin according to the Investigator's Global Assessment: a... حسب Jonathan I. Silverberg, Eric L. Simpson, Marius Ardeleanu, Diamant Thaçi, S. Barbarot, Jerry Bagel, Z. Chen, Laurent Eckert, J. Chao, Andrew Korotzer, E. Rizova, Ana B. Rossi, Yuan Lü, NM Graham, Thomas Hultsch, Gianluca Pirozzi, Bolanle Akinlade

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Laboratory safety of dupilumab in moderate-to-severe atopic dermatitis: results from three phase III trials (LIBERTY AD SOLO 1, LIBERTY AD SOLO 2, LIBERTY AD CHRONOS)

    Laboratory safety of dupilumab in moderate-to-severe atopic dermatitis: results from three phase III trials (LIBERTY AD SOLO 1, LIBERTY AD SOLO 2, LIBERTY AD CHRONOS) حسب Andreas Wollenberg, Lisa A. Beck, Andrew Blauvelt, Eric L. Simpson, Z. Chen, Q. Chen, Brad Shumel, Faisal A. Khokhar, Thomas Hultsch, E. Rizova, Ana B. Rossi, Neil M.H. Graham, Gianluca Pirozzi, Yuan Lü, Marius Ardeleanu

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    IL-4Rα Blockade by Dupilumab Decreases Staphylococcus aureus Colonization and Increases Microbial Diversity in Atopic Dermatitis

    IL-4Rα Blockade by Dupilumab Decreases Staphylococcus aureus Colonization and Increases Microbial Diversity in Atopic Dermatitis حسب Chris Callewaert, Teruaki Nakatsuji, Rob Knight, Tomasz Kościółek, Alison Vrbanac, Paul F. Kotol, Marius Ardeleanu, Thomas Hultsch, Emma Guttman‐Yassky, Robert Bissonnette, Jonathan I. Silverberg, James G. Krueger, Alan Menter, Neil M.H. Graham, Gianluca Pirozzi, Jennifer D. Hamilton, Richard L. Gallo

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Clinically Meaningful Responses to Dupilumab in Adolescents with Uncontrolled Moderate-to-Severe Atopic Dermatitis: Post-hoc Analyses from a Randomized Clinical Trial

    Clinically Meaningful Responses to Dupilumab in Adolescents with Uncontrolled Moderate-to-Severe Atopic Dermatitis: Post-hoc Analyses from a Randomized Clinical Trial حسب Amy S. Paller, Ashish Bansal, Eric L. Simpson, Mark Boguniewicz, Andrew Blauvelt, Elaine C. Siegfried, Emma Guttman‐Yassky, Thomas Hultsch, Zhen Chen, Paola Mina‐Osorio, Yufang Lü, Ana B. Rossi, Xinyi He, Mohamed Kamal, Neil M.H. Graham, Gianluca Pirozzi, Marcella Ruddy, Laurent Eckert, Abhijit Gadkari

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    Dupilumab Improves Asthma and Sinonasal Outcomes in Adults with Moderate to Severe Atopic Dermatitis

    Dupilumab Improves Asthma and Sinonasal Outcomes in Adults with Moderate to Severe Atopic Dermatitis حسب Mark Boguniewicz, Lisa A. Beck, Lawrence Sher, Emma Guttman‐Yassky, Diamant Thaçi, Andrew Blauvelt, Margitta Worm, Jonathan Corren, Weily Soong, Peter Lio, Ana B. Rossi, Yufang Lü, Jingdong Chao, Laurent Eckert, Abhijit Gadkari, Thomas Hultsch, Marcella Ruddy, Leda Mannent, Neil M.H. Graham, Gianluca Pirozzi, Zhen Chen, Marius Ardeleanu

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Dupilumab in adolescents with uncontrolled moderate‐to‐severe atopic dermatitis: results from a phase <scp>II</scp> a open‐label trial and subsequent phase <scp>III</scp> open‐label extension

    Dupilumab in adolescents with uncontrolled moderate‐to‐severe atopic dermatitis: results from a phase <scp>II</scp> a open‐label trial and subsequent phase <scp>III</scp> open‐labe... حسب Michael J. Cork, Diamant Thaçi, Lawrence F. Eichenfield, Peter D. Arkwright, Thomas Hultsch, John D. Davis, Y. Zhang, Xiaoping Zhu, Z. Chen, M. Li, Marius Ardeleanu, Ariel Teper, Bolanle Akinlade, A. Gadkari, Laurent Eckert, Mohamed Kamal, M. Ruddy, Neil M.H. Graham, Gianluca Pirozzi, Neil Stahl, A. Thomas DiCioccio, Ashish Bansal

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    Efficacy and Safety of Multiple Dupilumab Dose Regimens After Initial Successful Treatment in Patients With Atopic Dermatitis

    Efficacy and Safety of Multiple Dupilumab Dose Regimens After Initial Successful Treatment in Patients With Atopic Dermatitis حسب Margitta Worm, Eric L. Simpson, Diamant Thaçi, Robert Bissonnette, J.‐P. Lacour, Stefan Beissert, Makoto Kawashima, Carlos Ferrándiz, Catherine Smith, Lisa A. Beck, Kuo‐Chen Chan, Zhen Chen, Bolanle Akinlade, Thomas Hultsch, Heribert Staudinger, Abhijit Gadkari, Laurent Eckert, John D. Davis, Manoj Rajadhyaksha, Neil M.H. Graham, Gianluca Pirozzi, Neil Stahl, George D. Yancopoulos, Marius Ardeleanu

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis

    Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis حسب Eric L. Simpson, Amy S. Paller, Elaine C. Siegfried, Mark Boguniewicz, Lawrence Sher, Melinda Gooderham, Lisa A. Beck, Emma Guttman‐Yassky, David M. Pariser, Andrew Blauvelt, Jamie Weisman, Benjamin Lockshin, Thomas Hultsch, Qin Zhang, Mohamed Kamal, John D. Davis, Bolanle Akinlade, Heribert Staudinger, Jennifer D. Hamilton, Neil M.H. Graham, Gianluca Pirozzi, Abhijit Gadkari, Laurent Eckert, Neil Stahl, George D. Yancopoulos, Marcella Ruddy, Ashish Bansal

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    Conjunctivitis in dupilumab clinical trials

    Conjunctivitis in dupilumab clinical trials حسب Bolanle Akinlade, Emma Guttman‐Yassky, Marjolein de Bruin‐Weller, Eric L. Simpson, Andrew Blauvelt, Michael J. Cork, Errol P. Prens, Penny A. Asbell, Esen K. Akpek, Jonathan Corren, Claus Bachert, Ikuo Hirano, Jonathan Weyne, Andrew Korotzer, Z. Chen, Thomas Hultsch, Xiaoping Zhu, John D. Davis, Leda Mannent, Jennifer D. Hamilton, Ariel Teper, Heribert Staudinger, E. Rizova, Gianluca Pirozzi, Neil M.H. Graham, Brad Shumel, Marius Ardeleanu, Andreas Wollenberg

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: